Main sources of the formation of contingents of tuberculosis patients with drug-resistant or sensitive Mycobacterium tuberculosis isolates
Zhukova, M.P.
Problemy Tuberkuleza 4: 4-5
1998
ISSN/ISBN: 0032-9533 PMID: 9771024 Document Number: 496752
To form contingents of pulmonary tuberculosis patients with isolated drug-resistant Mycobacteria tuberculosis (MBT) strains, chronic patients having the disease for more than 3 years (50.3%) head the list, new cases (36.9%) detected in the past 3 years (1994-1996) rank second, next are those with relapsing tuberculosis (12.8%) identified in 1994-1996. The ratio of the above group of patients with isolated drug-sensitive MBT species is 23.3, 68.8, and 7.9%, respectively.
Document emailed within 1 workday
Related Documents
Paramasivan, C.N.; Venkataraman, P.; Herbert, D. 1997: Minimal inhibitory concentrations of sulbactam/ampicillin against drug sensitive and drug resistant isolates of Mycobacterium tuberculosis Microbios 89: 360-361Therese, K.L.; Gayathri, R.; Dhanurekha, L.; Sridhar, R.; Meenakshi, N.; Madhavan, H.N.; Manoj, S.E.; Vinayagam, A.K. 2012: Detection of Mycobacterium tuberculosis directly from sputum specimens and phenotypic drug resistance pattern of M. tuberculosis isolates from suspected tuberculosis patients in Chennai Indian Journal of Medical Research 135(5): 778-782
Imwidthaya, P.; Mieskes, K.; Rienthong, S. 2001: Evaluation of katG codon 315 mutations among isoniazid sensitive and resistant mycobacterium tuberculosis isolates from Thailand Journal of the Medical Association of Thailand 84(6): 864-869
Sulistijawati, R.Sri.; Icksan, A.Ghanie.; Lolong, D.Bisara.; Nurwidya, F. 2019: Thoracic Radiography Characteristics of Drug Sensitive Tuberculosis and Multi Drug Resistant Tuberculosis: A Study of Indonesian National Tuberculosis Prevalence Survey Acta Medica 62(1): 24-29
Lee, A.S.G.; Tang, L.L.H.; Lim, I.H.K.; Wong, S.Yew. 2002: Characterization of pyrazinamide and ofloxacin resistance among drug resistant Mycobacterium tuberculosis isolates from Singapore International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 6(1): 48-51
Foroumadi, A.; Soltani, F. 2003: Antituberculosis agents. IX. in vitro antimycobacterial activity of N-(2-phenyl-2-oxoethyl) and N-[2-(4-fluorophenyl)-2-oxoethyl]ciprofloxacin derivatives against some drug-resistant strains of Mycobacterium tuberculosis and Mycobacterium avium isolates Bollettino Chimico Farmaceutico 142(6): 248-250
Hong, C.-Y.; Wang, F.; Gui, J.; Liu, X.-l. 2012: Characteristics of pncA gene in multidrug-resistant Mycobacterium tuberculosis isolates and its correlation with drug resistance to pyrazinamide Zhonghua Yu Fang Yi Xue Za Zhi 46(5): 436-439
Katalinić-Janković, V.; Obrovac, M. 2004: Drug-resistant tuberculosis: resistance mechanisms and drug susceptibility of Mycobacterium tuberculosis Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 58(4): 323-328
Firsova, V.A.; Rusakova, L.I.; Grigor'eva, Z.P.; Ryzhova, A.P.; Iatskova, T.V.; Poluéktova, F.G. 2001: Approaches to combined therapy of pulmonary tuberculosis in adolescents excreting drug-resistant Mycobacterium tuberculosis Problemy Tuberkuleza 1: 28-30
Kulkarni, S.; Sola, C.; Filliol, I.; Rastogi, N.; Kadival, G. 2005: Spoligotyping of Mycobacterium tuberculosis isolates from patients with pulmonary tuberculosis in Mumbai, India Research in Microbiology 156(4): 588-596
González, N.; Torres, M.J.; Palomares, J.C.; Aznar, J. 1998: Characterization of the rpoB gene mutations in clinical isolates of rifampicin-resistant Mycobacterium tuberculosis Enfermedades Infecciosas y Microbiologia Clinica 16(9): 404-407
Foroumadi, A.; Soltani, F.; Moshafi, M.H. 2002: Antituberculosis agents. VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis Bollettino Chimico Farmaceutico 141(5): 394-396
Coban, A.Y.; Bilgin, K.; Uzun, M.; Durupinar, B. 2009: Effect of linezolid in combination with isoniazid and rifampicin against multidrug resistant Mycobacterium tuberculosis clinical isolates Mikrobiyoloji Bulteni 43(2): 293-297
Ahmad, B.; Idrees, M.; Ahmad, K.; Bashir, S.; Jamil, S. 2017: Molecular characterisation of isoniazid resistant clinical isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan Jpma. Journal of the Pakistan Medical Association 67(8): 1224-1227
Ahmad, S.; Al-Mutairi, N.M.; Mokaddas, E. 2009: Comparison of performance of two DNA line probe assays for rapid detection of multidrug-resistant isolates of Mycobacterium tuberculosis Indian Journal of Experimental Biology 47(6): 454-462
Korotaev, G.A.; Kozulitsyna, T.I.; Tret'iakova, E.A.; Mamed'iarova, F.A. 1986: Clinical and bacteriological aspects of the drug resistance of Mycobacterium tuberculosis in patients with chronic destructive pulmonary tuberculosis Problemy Tuberkuleza 7: 32-36
Magana-Arachchi, D.N.; Perera, A.J.; Senaratne, V.; Chandrasekharan, N.V. 2010: Patterns of drug resistance and RFLP analysis of Mycobacterium tuberculosis strains isolated from recurrent tuberculosis patients in Sri Lanka Southeast Asian Journal of Tropical Medicine and Public Health 41(3): 583-589
Almeida, D.; Rodrigues, C.; Ashavaid, T.F.; Lalvani, A.; Udwadia, Z.F.; Mehta, A. 2005: High incidence of the Beijing genotype among multidrug-resistant isolates of Mycobacterium tuberculosis in a tertiary care center in Mumbai, India Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 40(6): 881-886
Alrajhi, A.A. 2002: Drug-resistant Mycobacterium tuberculosis in Saudi Arabia: how little we know Annals of Saudi Medicine 22(3-4): 141-142
Dheda, K. 2009: Extensively drug-resistant Mycobacterium tuberculosis: what are these bugs up to in India? Indian Journal of Medical Research 130(4): 357-358